Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Oxford Pharmaceutical Resources, Inc. is a specialized consulting clinical and regulatory organization (CRO) based in Totowa, New Jersey. Founded and led by Dr. Richard A. Guarino, a renowned expert in the drug approval process and author of the 'New Drug Approval Process' textbook, the firm provides strategic guidance to pharmaceutical and biotechnology companies. Their core services include the planning, implementation, and submission of Investigational New Drug (IND) and New Drug Applications (NDA) in the Common Technical Document (CTD) format. The company also offers expertise in Good Clinical Practice (GCP) training, clinical trial protocol design, and FDA liaison services to facilitate the efficient development and approval of new therapeutic products.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Oxford Pharmaceutical Resources.